Table 1. Correlation between clinicopathological features and CDK5 expression levels.
Variables | n |
CDK5 expression |
χ2 a | P | |
---|---|---|---|---|---|
Low | High | ||||
Gender | 0.32 | 0.572 | |||
Male | 46 | 22 | 24 | ||
Female | 43 | 18 | 25 | ||
Age (years) | 0.103 | 0.748 | |||
<59 | 26 | 11 | 15 | ||
⩾59 | 63 | 29 | 34 | ||
Tumor size (cm in diameter) | 10.156 | 0.001 | |||
<5 | 37 | 24 | 13 | ||
⩾5 | 52 | 16 | 36 | ||
Nodal metastasis | 4.867 | 0.027 | |||
N0 | 58 | 31 | 27 | ||
N1/2 | 31 | 9 | 22 | ||
Differentiation | 6.619 | 0.034 | |||
Well | 21 | 14 | 7 | ||
Moderate | 55 | 23 | 32 | ||
Poor | 13 | 3 | 10 | ||
AJCC stage | 6.619 | 0.01 | |||
I/II | 56 | 31 | 25 | ||
III/IV | 33 | 9 | 24 |
Pearson's chi-square was used for the assay. Significant at P<0.05